ERBB2 amplification is superior to protein expression status in predicting patient outcome in serous ovarian carcinoma

Heini Lassus, Arto Leminen, Aki Vayrynen, Guojun Cheng, Jan Åke Gustafsson, Jorma Isola, Ralf Butzow

Research output: Contribution to journalArticle

81 Scopus citations

Fingerprint Dive into the research topics of 'ERBB2 amplification is superior to protein expression status in predicting patient outcome in serous ovarian carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences